Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biora AB Malmo, Sweden Releases Q3 Report.


MALMO, Sweden--(BUSINESS WIRE)--Nov. 3, 1999--
            INTERIM REPORT FOR THE FIRST NINE MONTHS 1999
                            Biora AB (publ)

                        Home page www.biora.se
                           November 3, 1999

                                                            Including
                                                         nonrecurring
                                                              revenue

The first nine months             1999            1998         1998

Net sales, SEK millions           52.2            35.4           -

Operating loss, SEK millions    - 64.8   -        80.9      - 41.5 (1)

Net loss, SEK millions          - 60.7   -        71.6      - 32.2 (1)

(1) First quarter of 1998 includes nonrecurring revenue from
Seikagaku Corporation, Biora's Japanese partner.

--    Sales during the first nine months 1999 increased by 48 percent
      to SEK 52.2 million (compared with SEK 35.4 million for the same
      period in 1998) and during the third quarter with 18 percent to
      SEK 14.7 million (compared with SEK 12.5 million in 1998). The
      increase was mainly in the U.S. market.

--    Emdogain was approved in the United States for a new
      application, multiplying the market potential several times.

--    A new subsidiary, Biora BioEx AB, was formed to focus on R&D on
      products for treatment of wounds and infections outside the oral
      cavity.

--    Documentation for licensing pre-mixed product, Emdogain(R)
      Gel, was submitted in Europe.

--    Biora Inc. received "1999 Swedish Trade Council North America
      Annual Achievement Award"


Biora AB (Nasdaq:BIORY) develops, manufactures and sells products for the treatment of periodontal disease Periodontal Disease Definition

Periodontal diseases are a group of diseases that affect the tissues that support and anchor the teeth. Left untreated, periodontal disease results in the destruction of the gums, alveolar bone (the part of the jaws where
 and for use in oral surgery. Using its proprietary technology and expertise, Biora aims to become a world leader in biology-based products for specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 dental therapy.

Biora's American American, river, 30 mi (48 km) long, rising in N central Calif. in the Sierra Nevada and flowing SW into the Sacramento River at Sacramento. The discovery of gold at Sutter's Mill (see Sutter, John Augustus) along the river in 1848 led to the California gold rush of  Depository The place where a deposit is placed and kept, e.g., a bank, savings and loan institution, credit union, or trust company. A place where something is deposited or stored as for safekeeping or convenience, e.g., a safety deposit box.  Shares are listed on the Nasdaq National Market in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and Biora's ordinary shares are listed on the "O-list" of the Stockholm Stock Exchange The Stockholm Stock Exchange (Swedish: Stockholmsbörsen) is a stock exchange located in Stockholm, Sweden. Founded in 1863 [1] it is the primary securities exchange of the Nordic Countries.  in Sweden Sweden, Swed. Sverige, officially Kingdom of Sweden, constitutional monarchy (2005 est. pop. 9,002,000), 173,648 sq mi (449,750 sq km), N Europe, occupying the eastern part of the Scandinavian peninsula. .

This report may contain certain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 that relate to the future events or future business and financial performance. Such statements can only be predictions and the actual events or results may differ from those discussed. The company cautions that these statements are subject to important factors that could cause actual results to differ materially from those expressed or implies in such forward looking statements and are more fully discussed in periodic reports filed with the Securities and Exchange Commission.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 3, 1999
Words:356
Previous Article:Highland Capital Corp Announces Opening of a Marketing Office.
Next Article:Agilent Technologies Ships Its 1-Millionth CMOS Image Sensor.
Topics:



Related Articles
Biora AB Interim Report, First Quarter 1999.
Biora AB Interim Report, First Quarter 1999.
Biora AB Issues Half Year Report.
Biora's Principal Product Emdogain Gained Recognition At Specialist-Conference In The United States.
Year End Report 1999 for Biora AB.
Biora Appoints New General Manager in Germany.
Rickard Soderberg new CEO for Biora AB.
Biora AB Report for the First Half Year 2000.
Biora Increases Its Focus On the Dental Market.
Altered Production Process for Japan.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles